Skip to main content
. 2026 Jan 29;17(2):153. doi: 10.3390/genes17020153
NMIBC Non-muscle-invasive bladder cancer
MIBC Muscle-invasive bladder cancer
BCG Bacillus Calmette–Guérin
BRS (BRS1–3) BCG Response Subtypes
CISTO Comparison of Intravesical Therapy and Surgery as Treatment Options
TURBT Transurethral resection of the bladder tumor
EORTC European Organization for Research and Treatment of Cancer
CUETO Spanish Urological Club for Oncological Treatment
CIS Carcinoma in situ
LVI Lymphovascular invasion
RFS Recurrence-free survival
PFS Progression-free survival
GI Genome instability (subtype)
AA-like Aristolochic acid-associated (subtype)
EMT Epithelial-to-mesenchymal transition
Tregs Regulatory T cells
MDSCs Myeloid-derived suppressor cells
IDO1 Indoleamine 2,3-dioxygenase
lncRNAs Long non-coding RNAs
RC Radical cystectomy
BST Bladder-sparing therapy